Market research
FORA Forian Inc
NASDAQ USD Healthcare
Latest close
As of 14 Aug 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 68M
- P/E ratio
- Not available
- Analyst target
- 2.1
- Dividend yield
- Not available
- Beta
- 0.93
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- Not available
- Market cap
- 68M
- P/E ratio
- Not available
- Analyst target
- 2.1
- Dividend yield
- Not available
- Beta
- 0.93
About
About Forian Inc
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc. operates as a subsidiary of 2025 Acquisition Company, LLC.
Research context
Forian Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the FORA discussion.
5 years, 7 months ago
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Forian Inc gets an overall score of 1/5.